Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Maria Raptopoulou-Gigi"'
Autor:
Vincent, Rijckborst, Peter, Ferenci, Meral, Akdogan, Binnur, Pinarbasi, Martijn J, ter Borg, Krzysztof, Simon, Robert, Flisiak, Ulus S, Akarca, Maria, Raptopoulou-Gigi, Elke, Verhey, Anneke J, van Vuuren, Charles A, Boucher, Bettina E, Hansen, Harry L A, Janssen, F, Tabak
Publikováno v:
European Journal of Gastroenterology & Hepatology, 24(9), 1012-1019. Lippincott Williams & Wilkins
OBJECTIVE Peginterferon (PEG-IFN) is considered as a first-line treatment option for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B. We aimed to evaluate the long-term response to PEG-IFN in HBeAg-negative patients. METHODS All patients e
Autor:
George N. Dalekos, Christos Triantos, Konstantinos Mimidis, Christos Drakoulis, Ioannis Goulis, Evangelos Akriviadis, S. Karatapanis, George Germanidis, Maria Raptopoulou-Gigi, Georgios Bakalos, Elias Zintzaras, Melanie Deutsch, George V. Papatheodoridis
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 35(5)
Background & Aims We assessed predictors of response in HBeAg-negative chronic hepatitis B patients treated with peginterferon alfa-2a in routine clinical practice. Methods Ninety-five HBeAg-negative patients received peginterferonalfa-2a for 48 week
Publikováno v:
European Journal of Epidemiology. 17:263-266
The prevalence of hepatitis C virus (HCV) infection and the mother-to-child transmission of HCV were studied in 2408 pregnant women. Positive antiHCV were detected in 47 women (1.95%), 21 of whom (44.7%) were HCVRNA(+), but only seven had abnormal am
Autor:
Christos Tanis, Emmanouil Sinakos, E. Gigi, Aristea-Lia Bellou, Eleni Orfanou, Albana Sykja, Effrosyni Tsirogianni, Maria Raptopoulou-Gigi, Georgios Androulakis, Victoria Stayridou, Konstantinos Zouridakis
Publikováno v:
Journal of addiction medicine. 7(1)
Objectives The aim of this study was to evaluate retrospectively the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, epidemiological parameters, and the clinical data from the antiviral treatment of hepatitis C in a large
Autor:
Georgia Vourli, I. Ketikoglou, Themistoklis Vasiliadis, Spilios Manolakopoulos, Maria Raptopoulou-Gigi, Giota Touloumi, Emanuel K. Manesis, Kostas Mimidis, George V. Papatheodoridis, Irini Vafiadis-Zoumbouli, Charalambos Gogos
Publikováno v:
Gut. 60(8)
To evaluate the risk and predictors of hepatocellular carcinoma (HCC) in HBeAg-negative chronic hepatitis B patients of the large HEPNET.Greece cohort study who received long-term oral antivirals starting with lamivudine monotherapy.Retrospective ana
Autor:
Vasilios Perifanis, Emmanouil Sinakos, Maria Raptopoulou-Gigi, Ioanna Tsatra, Efthimia Vlachaki
Publikováno v:
British Journal of Haematology.
Autor:
Eleni, Gigi, Thalia, Lalla, Eleni, Orphanou, Emmanuel, Sinakos, Eleni, Vrettou, Maria, Raptopoulou-Gigi
Publikováno v:
Journal of gastrointestinal and liver diseases : JGLD. 16(1)
To investigate the long-term outcome and the risk of progression to chronic hepatitis B in inactive hepatitis B surface antigen carriers.A total of 307 HBsAg (+)/HBeAg (-)/antiHBe (+) subjects with initially normal alanine aminotransferase (ALT) leve
Publikováno v:
Clinical and experimental immunology. 146(3)
Summary Despite treatment, 10–30% of brucellosis patients develop chronic disease, characterized by atypical clinical picture and/or relapses. A defective T helper 1 (Th1) response and a long percentage of CD4+/CD25+ cells have been described in ch
Publikováno v:
The Journal of infection. 54(2)
Summary Objectives and methods Despite the treatment, a considerable proportion of brucellosis patients develop chronic disease, characterized by atypical clinical picture and/or relapses. Th1 cytokines are critical for the clearance of Brucella infe
Autor:
Georgios Grollios, Apostolos H. Karantanas, Maria Raptopoulou-Gigi, Amalia Raptopoulou, Alexandros Garyfallos, Kiriakos Poumboulidis
Publikováno v:
Clinical imaging. 30(3)
Brucellosis is a zoonosis of worldwide distribution presenting with a wide clinical spectrum. Brucellosis can involve any organ or system. The axial skeleton is the most common site of involvement with a frequency ranging from 2% to 53%. Multiple-lev